These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 23895631)
21. Atopic disease and exhaled nitric oxide in an unselected population of young adults. van Asch CJ; Balemans WA; Rovers MM; Schilder AG; van der Ent CK Ann Allergy Asthma Immunol; 2008 Jan; 100(1):59-65. PubMed ID: 18254484 [TBL] [Abstract][Full Text] [Related]
22. Protective and risk factors for allergic diseases in high-risk children at the ages of two and five years. Sandini U; Kukkonen AK; Poussa T; Sandini L; Savilahti E; Kuitunen M Int Arch Allergy Immunol; 2011; 156(3):339-48. PubMed ID: 21720181 [TBL] [Abstract][Full Text] [Related]
23. Probiotics during weaning: a follow-up study on effects on body composition and metabolic markers at school age. Karlsson Videhult F; Öhlund I; Stenlund H; Hernell O; West CE Eur J Nutr; 2015 Apr; 54(3):355-63. PubMed ID: 24830782 [TBL] [Abstract][Full Text] [Related]
24. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. Abrahamsson TR; Jakobsson T; Böttcher MF; Fredrikson M; Jenmalm MC; Björkstén B; Oldaeus G J Allergy Clin Immunol; 2007 May; 119(5):1174-80. PubMed ID: 17349686 [TBL] [Abstract][Full Text] [Related]
25. Perinatal probiotic intervention prevented allergic disease in a Caesarean-delivered subgroup at 13-year follow-up. Kallio S; Kukkonen AK; Savilahti E; Kuitunen M Clin Exp Allergy; 2019 Apr; 49(4):506-515. PubMed ID: 30472801 [TBL] [Abstract][Full Text] [Related]
26. High intestinal IgA associates with reduced risk of IgE-associated allergic diseases. Kukkonen K; Kuitunen M; Haahtela T; Korpela R; Poussa T; Savilahti E Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 1):67-73. PubMed ID: 19566584 [TBL] [Abstract][Full Text] [Related]
27. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. Kukkonen K; Savilahti E; Haahtela T; Juntunen-Backman K; Korpela R; Poussa T; Tuure T; Kuitunen M J Allergy Clin Immunol; 2007 Jan; 119(1):192-8. PubMed ID: 17208601 [TBL] [Abstract][Full Text] [Related]
28. Probiotics in late infancy reduce the incidence of eczema: A randomized controlled trial. Schmidt RM; Pilmann Laursen R; Bruun S; Larnkjaer A; Mølgaard C; Michaelsen KF; Høst A Pediatr Allergy Immunol; 2019 May; 30(3):335-340. PubMed ID: 30790361 [TBL] [Abstract][Full Text] [Related]
29. Interaction of NPSR1 genotypes and probiotics in the manifestation of atopic eczema in early childhood. P K; M K; K K; T L; M K Allergol Immunopathol (Madr); 2014; 42(6):560-7. PubMed ID: 24439655 [TBL] [Abstract][Full Text] [Related]
30. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Viljanen M; Savilahti E; Haahtela T; Juntunen-Backman K; Korpela R; Poussa T; Tuure T; Kuitunen M Allergy; 2005 Apr; 60(4):494-500. PubMed ID: 15727582 [TBL] [Abstract][Full Text] [Related]
31. Timing of solid food introduction in relation to eczema, asthma, allergic rhinitis, and food and inhalant sensitization at the age of 6 years: results from the prospective birth cohort study LISA. Zutavern A; Brockow I; Schaaf B; von Berg A; Diez U; Borte M; Kraemer U; Herbarth O; Behrendt H; Wichmann HE; Heinrich J; Pediatrics; 2008 Jan; 121(1):e44-52. PubMed ID: 18166543 [TBL] [Abstract][Full Text] [Related]
32. Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses. Taylor AL; Hale J; Wiltschut J; Lehmann H; Dunstan JA; Prescott SL Clin Exp Allergy; 2006 Oct; 36(10):1227-35. PubMed ID: 17014429 [TBL] [Abstract][Full Text] [Related]
33. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. Taylor AL; Dunstan JA; Prescott SL J Allergy Clin Immunol; 2007 Jan; 119(1):184-91. PubMed ID: 17208600 [TBL] [Abstract][Full Text] [Related]
34. Early predictors for developing allergic disease and asthma: examining separate steps in the 'allergic march'. Almqvist C; Li Q; Britton WJ; Kemp AS; Xuan W; Tovey ER; Marks GB; Clin Exp Allergy; 2007 Sep; 37(9):1296-302. PubMed ID: 17845409 [TBL] [Abstract][Full Text] [Related]
35. No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. Abrahamsson TR; Jakobsson T; Björkstén B; Oldaeus G; Jenmalm MC Pediatr Allergy Immunol; 2013 Sep; 24(6):556-61. PubMed ID: 23902407 [TBL] [Abstract][Full Text] [Related]
36. Children with allergic and nonallergic rhinitis have a similar risk of asthma. Chawes BL; Bønnelykke K; Kreiner-Møller E; Bisgaard H J Allergy Clin Immunol; 2010 Sep; 126(3):567-73.e1-8. PubMed ID: 20816191 [TBL] [Abstract][Full Text] [Related]
37. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Chen YS; Jan RL; Lin YL; Chen HH; Wang JY Pediatr Pulmonol; 2010 Nov; 45(11):1111-20. PubMed ID: 20658483 [TBL] [Abstract][Full Text] [Related]
38. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Osborn DA; Sinn JK Cochrane Database Syst Rev; 2007 Oct; (4):CD006475. PubMed ID: 17943912 [TBL] [Abstract][Full Text] [Related]
39. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Palmer DJ; Sullivan T; Gold MS; Prescott SL; Heddle R; Gibson RA; Makrides M Allergy; 2013 Nov; 68(11):1370-6. PubMed ID: 24111502 [TBL] [Abstract][Full Text] [Related]
40. Long-term safety and efficacy of perinatal probiotic intervention: Evidence from a follow-up study of four randomized, double-blind, placebo-controlled trials. Lundelin K; Poussa T; Salminen S; Isolauri E Pediatr Allergy Immunol; 2017 Mar; 28(2):170-175. PubMed ID: 27779809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]